Our 14,059 square meter Zhongli, Taiwan facility is designed for flexible, high-quality contract liquids, semi-solid and oral solid cGMP drug manufacturing. The facility offers best-in-class capabilities and access to the largest pharmaceutical markets in the world, including North America, European Union and China.
As a future-focused CDMO, we know better than most that our own success is shaped by our partners' victories. At Bora Pharmaceuticals, we see it as our mission, our duty, and our responsibility to deliver reliably on time, consistently in full.